Clinical Trial Update: The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity [Phase 3]

View source ↗

Summary

The PARTUM trial is a Phase 3 study evaluating postpartum aspirin to reduce venous thromboembolism. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Aspirin (Aspirin)
• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: University of Calgary | Conditions: Venous Thromboembolism, Postpartum Period | Phase 3 | Status: NOT_YET_RECRUITING